NEW YORK (GenomeWeb News) – The US Food and Drug Administration has approved Roche's HIV viral load test, the Swiss drug and diagnostics firm announced today.

The test, called Cobas TaqMan HIV-1 Test, v2.0, will be available later this year and targets two highly conserved regions of the HIV-1 genome, avoiding any regions that are targeted by current drugs. As a result, the test provides increased reliability "even with rare mismatches in primer/probe binding sites and when mutations are present," Roche said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.